Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foster

Showing results (1171-1180 of 1,472) with videos related to

Pageof 148
Sort By:
Circulation|October 19, 2011
Improved cardiac risk assessment with noninvasive measures of coronary flow reserveVenkatesh L Murthy, Masanao Naya, Courtney R Foster, et al.
American Journal of Physiology. Renal Physiology|March 10, 2006
VEGF-C promotes survival in podocytesR R Foster, S C Satchell, J Seckley, et al.
European Journal of Clinical Pharmacology|September 18, 2007
Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteersMette L Jensen, David J R Foster, Richard N Upton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumorsAminah Jatoi, Gamini Soori, Nathan R Foster, et al.
Plos One|July 21, 2012
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trialShernan G Holtan, Preston D Steen, Nathan R Foster, et al.
Biochemical Pharmacology|January 17, 2012
The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in ratsAlvin V Terry, Jerry J Buccafusco, R Foster Schade, et al.
Cancer|October 21, 2010
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trialsNathan R Foster, Yingwei Qi, Qian Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
IFN-alpha subtypes differentially affect human T cell motilityGraham R Foster, Siti H Masri, Rachel David, et al.
Frontline Gastroenterology|March 29, 2018
Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descentSampath De Silva, Wenhao Li, Polychronis Kemos, et al.
Revista Do Hospital Das Clinicas|July 1, 1989
[Evaluation of the usefulness of the Coprotest for parasitologic examination of feces]V Amato Neto, R Campos, P L Pinto, et al.
Pageof 148

Showing results (1171-1180 of 1,472) with videos related to

Sort By:
Pageof 148
Circulation|October 19, 2011
Improved cardiac risk assessment with noninvasive measures of coronary flow reserveVenkatesh L Murthy, Masanao Naya, Courtney R Foster, et al.
American Journal of Physiology. Renal Physiology|March 10, 2006
VEGF-C promotes survival in podocytesR R Foster, S C Satchell, J Seckley, et al.
European Journal of Clinical Pharmacology|September 18, 2007
Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteersMette L Jensen, David J R Foster, Richard N Upton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumorsAminah Jatoi, Gamini Soori, Nathan R Foster, et al.
Plos One|July 21, 2012
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trialShernan G Holtan, Preston D Steen, Nathan R Foster, et al.
Biochemical Pharmacology|January 17, 2012
The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in ratsAlvin V Terry, Jerry J Buccafusco, R Foster Schade, et al.
Cancer|October 21, 2010
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trialsNathan R Foster, Yingwei Qi, Qian Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
IFN-alpha subtypes differentially affect human T cell motilityGraham R Foster, Siti H Masri, Rachel David, et al.
Frontline Gastroenterology|March 29, 2018
Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descentSampath De Silva, Wenhao Li, Polychronis Kemos, et al.
Revista Do Hospital Das Clinicas|July 1, 1989
[Evaluation of the usefulness of the Coprotest for parasitologic examination of feces]V Amato Neto, R Campos, P L Pinto, et al.
Pageof 148